Dev-Res-Prog-001

开发-研究-Prog-001

• 批准号: 10019497
• 负责人: Tracy T Batchelor
• 金额: $ 8.87万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-19 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10019497
• 关键词: Award; Brain Neoplasms; Cancer Center; Communication; Data; Development; Funding; Future; Glioma; Goals; Infrastructure; Institution; Measures; Monitor; Outcome; Patients; Pilot Projects; Process; Program Research Project Grants; Progress Reports; Request for Proposals; Research; Research Project Grants; Scientist; experience; innovation; programs; targeted treatment

The objective of the Glioma SPORE Developmental Research Program (DRP) is to identify innovative pilot research projects in glioma that have translational potential. The DRP utilizes a solicitation and review process to select meritorious pilot projects for funding. The solicitation process capitalizes on an established, extensive Dana-Farber/Harvard Cancer Center (DF/HCC) communications infrastructure to widely disseminate an annual Request for Proposals (RFP). The review process utilizes an experienced panel of DF/HCC glioma scientists. The DRP provides limited-duration funding for innovative projects that have ultimate translational potential and could synergize with existing SPORE projects and cores. DF/HCC institutions match DRP funding from this SPORE to expand the pool of DRP awardees. The DRP applications are judged for their potential as pilot or collaborative studies that will generate feasibility data and for their ultimate potential to emerge as full projects in future years of the SPORE program. The DRP employs a monitoring process to measure progress and outcomes of DRP projects including the possible elevation of successful DRP awards to full projects. The program is closely monitored through clearly established metrics and oversight by the DRP Awards Committee. DRP awardees are required to present biannual progress reports.

胶质瘤 SPORE 发展研究计划 (DRP) 的目标是确定创新试点 具有转化潜力的神经胶质瘤研究项目。 DRP 采用征求和审查流程 选择优秀试点项目予以资助。招标过程利用了既定的、广泛的 丹娜—法伯癌症研究所/哈佛大学癌症中心 (DF/HCC) 通信基础设施广泛传播年度报告 征求建议书 (RFP)。审查过程由经验丰富的 DF/HCC 神经胶质瘤科学家组成。 DRP 为具有最终转化潜力和 可以与现有的 SPORE 项目和核心产生协同作用。 DF/HCC 机构由此匹配 DRP 资金 SPORE 扩大 DRP 获奖者的范围。 DRP 应用程序将根据其作为试点或 合作研究将生成可行性数据并发挥其作为完整项目的最终潜力 SPORE 计划的未来几年。 DRP 采用监控流程来衡量进展情况并 DRP 项目的成果，包括可能将成功的 DRP 奖励提升到完整项目。这 该计划通过 DRP 奖项明确制定的指标和监督进行密切监控 委员会。 DRP 获奖者必须每半年提交一次进度报告。